BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36415513)

  • 21. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.
    Kaleağasıoğlu F; Berger MR
    World J Gastroenterol; 2014 Oct; 20(40):14747-59. PubMed ID: 25356037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk.
    Xue R; Hua L; Xu W; Gao Y; Pang Y; Hao J
    Biomed Res Int; 2018; 2018():4283673. PubMed ID: 30519576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
    Sohrabi E; Rezaie E; Heiat M; Sefidi-Heris Y
    Biochem Genet; 2021 Oct; 59(5):1326-1358. PubMed ID: 33813720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
    Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
    Liu J; Li J; Li H; Li A; Liu B; Han L
    Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer.
    Ma C; Cui Z; Wang Y; Zhang L; Wen J; Guo H; Li N; Zhang W
    Bosn J Basic Med Sci; 2021 Feb; 21(1):47-60. PubMed ID: 33188589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of anoxic prognostic model on immune microenvironment in pancreatic cancer.
    Wu Y; Kou Q; Sun L; Hu X
    Sci Rep; 2023 Jun; 13(1):9104. PubMed ID: 37277450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of potential genes related to breast cancer brain metastasis in breast cancer patients.
    Zhang L; Wang L; Yang H; Li C; Fang C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34541602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of whole genomic expression profiles and screening of the key signaling pathways associated with pancreatic cancer.
    He C; Jiang H; Geng S; Sheng H; Shen X; Zhang X; Zhu S; Chen X; Yang C; Gao H
    Int J Clin Exp Pathol; 2012; 5(6):537-46. PubMed ID: 22949936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma.
    Luan H; He Y; Zhang T; Su Y; Zhou L
    BMC Cancer; 2022 Apr; 22(1):463. PubMed ID: 35477379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in pancreatic cancer detection.
    Tanase CP; Neagu M; Albulescu R; Hinescu ME
    Adv Clin Chem; 2010; 51():145-80. PubMed ID: 20857621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatics method to analyze the mechanism of pancreatic cancer disorder.
    Wang CJ; Xu RH; Yuan QY; Wang YK; Shen DW; Wang XJ; Gao W; Zhang H; Jiang H
    J Comput Biol; 2013 Jun; 20(6):444-52. PubMed ID: 23614574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer.
    Dahlem C; Barghash A; Puchas P; Haybaeck J; Kessler SM
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microarray-based gene expression profiling reveals genes and pathways involved in the oncogenic function of REG3A on pancreatic cancer cells.
    Xu Q; Fu R; Yin G; Liu X; Liu Y; Xiang M
    Gene; 2016 Mar; 578(2):263-73. PubMed ID: 26719042
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Ye H; Li T; Wang H; Wu J; Yi C; Shi J; Wang P; Song C; Dai L; Jiang G; Huang Y; Yu Y; Li J
    Front Immunol; 2021; 12():649551. PubMed ID: 33815409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.